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Abstract
The role of the carboxyl-terminal domain in rhodopsin transport was investigated using transgenic mice expressing a rhodopsin
truncation mutant lacking the terminal 15 amino acids (S334ter). It was previously shown that S334ter translocates to the outer
segment in the presence of endogenous rhodopsin. We now show that in the absence of endogenous rhodopsin S334ter mis-localizes
to the plasma membrane and fails to reconstitute outer segment structures. Surprisingly, this mis-localization does not aﬀect
photoreceptor cell survival. These results provide further evidence on the important role of the COOH-terminal domain in rho-
dopsin traﬃcking and demonstrate an absolute requirement of this domain for correct vectorial transport of rhodopsin in rod
photoreceptors.  2002 Elsevier Science Ltd. All rights reserved.
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1. Introduction
The rod outer segment is an apical appendage of
retinal rod photoreceptor cells that is specialized for
transducing the light signal. This specialization is re-
ﬂected by the extensive membranous disc stacks con-
taining a near crystalline array of the light-capturing
molecule, rhodopsin. In each rod outer segment there
are approximately 5 107 molecules of rhodopsin em-
bedded within the discs and the plasma membrane.
Rhodopsin comprises about 85% of the total protein in
the rod outer segment and is localized almost exclusively
to this structure. Transducin, phosphodiesterase and
other proteins involved in phototransduction make
up the majority of other proteins found in the outer
segment. How the proteins involved in the signaling
cascades are vectorially transported to this apical ap-
pendage of rod cells is not well understood.
There are over a hundred naturally occurring muta-
tions in the rhodopsin gene that lead to autosomal
dominant retinitis pigmentosa (Sohocki et al., 2001).
Some of these mutations are clustered around the highly
conserved carboxyl-terminus of the rhodopsin molecule,
e.g., P347L, P347S, P347R, V345M, Q344ter and two
frameshift mutations fs341del (Horn et al., 1992). Ex-
pression of some of these mutant proteins in COS-1 cells
failed to reveal a biochemical defect (Kaushal & Khor-
ana, 1994; Sung, Makino, Baylor, & Nathans, 1994;
Sung, Sneider, Agarwal, Papermaster, & Nathans,
1991). However, the fact that these mutations lead to
retinal degeneration suggests that the carboxyl-terminal
domain participates in an important physiological pro-
cess distinct from phototransduction.
A role of the carboxyl-terminal domain in rhodop-
sin transport was ﬁrst suggested by transgenic animal
studies. Studies on transgenic mice expressing the
Q344ter (Sung et al., 1994), P347S (Li, Snyder, Olsson,
& Dryja, 1996) and also transgenic rats expressing
S334ter (Green, Menz, Lavail, & Flannery, 2000) in the
presence of endogenous rhodopsin showed extensive
mis-localization of rhodopsin to the plasma membrane
and inner segments, where it is normally found in very
low levels (Hicks & Barnstable, 1987; Hicks, Sparrow, &
Barnstable, 1989; Nir & Papermaster, 1983). Analysis
using speciﬁc antibodies attributed this mis-localization
exclusively to the mutant rhodopsins (Green et al., 2000;
Li et al., 1996; Sung et al., 1994). These observations
suggest a defect in transport or retention of these mutant
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rhodopsin molecules in the outer segment. Nevertheless,
in these studies the majority of the mutant rhodopsin
molecules were correctly localized to the outer segment
along with the endogenous rhodopsin. Therefore, it is
uncertain whether the correct localization was due to co-
transport of mutant rhodopsin molecules with normal
endogenous rhodopsin in post-Golgi vesicles or whether
there are other site(s) on the rhodopsin molecule distinct
from the carboxyl-terminus domain that also contain(s)
signals for transport.
The in vivo role of the rhodopsin carboxyl-terminal
domain has also been investigated using transgenic
Xenopus laevis. Tam, Moritz, Hurd, and Papermaster
(2000) reported that the terminal 44 amino acid cyto-
plasmic tail of rhodopsin redirects a GFP fusion protein
exclusively to the rod outer segment, but GFP fusion
proteins bearing the naturally occurring carboxyl-
terminal mutations show GFP ﬂuorescence at the outer
segment, plasma membrane and the inner segment.
This experiment established that the carboxyl-terminal
domain contains a signal for transport to the outer
segment, and that it alone is suﬃcient to target a het-
erologous protein to the correct location.
The role of the carboxyl-terminus in rhodopsin
transport is also supported by recent in vitro evidence.
Using a retinal cell-free system from frog retina, Deretic,
Puleo-Scheppke, and Trippe (1996) demonstrated that
an antibody against the rhodopsin COOH-terminus in-
hibits post-Golgi vesicle formation. A synthetic peptide
corresponding to the carboxyl-terminus of rhodopsin
also inhibited rhodopsin traﬃcking in post-Golgi vesi-
cles, but peptides bearing the naturally occurring mu-
tations, Q344ter, V345M, and P347S, did not show this
inhibition (Deretic, Schmerl, Hargrave, Arendt, &
McDowell, 1998). Interestingly, the carboxyl-domain
has been found to interact directly with Tctex-1, a dynein
light chain (Tai, Chuang, Bode, Wolfrum, & Sung,
1999). This ﬁnding provides a mechanistic model by
which vesicles bearing rhodopsin molecules might be
transported along the cytoskeleton towards the apical
surface of rod photoreceptor cells.
Together, the in vivo and in vitro evidence clearly
implicate the carboxyl-terminal domain in rhodopsin
transport. However, since all of the in vivo experiments
were performed in the presence of normal endogenous
rhodopsin, and since all of the mutant rhodopsin mol-
ecules showed correct localization to the outer segments,
the question remains whether the rhodopsin carboxyl-
terminus plays a necessary and essential role. To address
this question, we utilized a transgenic mouse line that
expressed a rhodopsin truncation mutant that lacks the
carboxyl-terminal 15 amino acid residues (S334ter). This
transgene was introduced into the rhodopsin þ=þ, þ=
and = backgrounds to see whether rhodopsin trans-
port can occur in the absence of the carboxyl-terminal
domain and in the absence of endogenous rhodopsin.
2. Materials and methods
2.1. Generation of mouse lines
All mice were treated in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and
Vision Research. Transgenic mice expressing the S334ter
form of rhodopsin (Chen, Makino, Peachey, Baylor, &
Simon, 1995) or S338A rhodopsin (Mendez et al., 2000;
Mendez, Krasnoperova, Lem, & Chen, 2000), a control
line, were mated with wildtype or rhodopsin knockout
mice (rho=) (Lem et al., 1999) to generate mice that
expressed the transgene in the þ=þ, þ=, or =
endogenous rhodopsin genetic background.
All mice were born and raised in constant darkness to
avoid retinal degeneration that might result from con-
stitutive signaling caused by S334ter rhodopsin (Chen
et al., 1995).
2.2. Genotype analysis by PCR and Southern blotting
Mice were genotyped by PCR ampliﬁcation and by
Southern blot analysis. Genomic DNA was obtained
from mouse-tail biopsy samples. The S334ter transgene
was detected with primers Rho2 (50 TGGGAGAT-
GACGACGCCTAA 30) and Rho3 (50 TGAGGGAG-
GGGTACAGATCC 30), while S338A transgene was
detected with primers mRH7.2 (50 GACGACGCCT-
CGGCCACCGTG 30) and mRH5 (50 GGAGCCTG-
CATGACCTCATCC 30).
Transgenic mice bred to rhodopsin = mice were
genotyped for the rodopsin locus. PCRwas performed to
detect the presence of the rod opsin null allele by using
primers Rh1.1 (50 GTGCCTGGAGTTGCGCTGTG-
GG 30) and Neo3 (50 CGGTGGATGTGGAATGTGT-
GCGAG30). To distinguish between hemizygous ðþ=Þ
and homozygous ð=Þ rhodopsin knockout mice,
Southern blot analysis was performed as described pre-
viously (Mendez, Krasnoperova et al., 2000).
2.3. Determination of transgene expression level
Transgene expression level was determined in each
line by quantitating the mutant-to-total rod opsin
transcript ratio in transgene-positive mice in the rho-
dopsin þ=þ background at post-natal days 21–26 (P21–
P26). Total RNA was isolated from individual retinas
using the Trizol Reagent (Invitrogen Corp., Carlsbad,
CA), and reverse transcription was performed to obtain
single stranded cDNA. PCR ampliﬁcation of cDNA was
performed with primers mRh4 (50 GAGCTCTTCCA-
TCTATAACCCGG 30) and mRh6 (50 GGCTGGA-
GCCACCTGGCTG 30), which hybridize to identical
sequences in the endogenous and transgenic loci and,
therefore, amplify both with equal eﬃciency. Labeling
of the PCR ampliﬁcation product was carried out by
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addition of 10 lCi of a-32P dCTP (3000 Ci/mmol) to
the PCR reaction. PCR ampliﬁcation products were
precipitated, washed, resuspended in dH2O, and divided
into two equal aliquots. One aliquot was digested with a
restriction enzyme speciﬁc for the transgene (DdeI for
S334ter; EaeI for S338A), and the other one was mock
digested. Both aliquots were then loaded in a 12% Bis–
Tris polyacrylamide gel (Invitrogen Corp., Carlsbad,
CA). The gel was dried, exposed and analyzed using
the Storm 860 Phosphor Imager software (Amersham
Pharmacia Biotech Inc., Piscataway, NJ).
2.4. Western blot analysis
Retinas were dissected out from dark-reared mice at
post-natal days 21–26, under infrared illumination. In-
dividual retinas were homogenized in homogenization
buﬀer (80 mM Tris–HCl, pH 8.0; 4 mMMgCl2; protease
inhibitor cocktail (Boehringer Mannheim, Indianapolis,
IN); and 0.5 mM phenylmethylsulfonyl ﬂuoride) and
incubated with DNase I (Boehringer Mannheim, India-
napolis, IN) for 30 min at room temperature. Laemmli
buﬀer was added, and the indicated amounts (in retina
equivalents) were separated in a 12% Tris–glycine poly-
acrylamide gel (Invitrogen Corp., Carlsbad, CA). Pro-
teins were transferred onto a nitrocellulose membrane
and incubated with mAb R2-12N (a generous gift from
Paul Hargrave, University of Florida, Gainesville), and
subsequently with goat anti-mouse IgG conjugated to
horseradishperoxidase (InvitrogenCorp.,Carlsbad,CA).
Immunodetection was performed using the ECL system
(Amersham Pharmacia Biotech Inc., Piscataway, CA).
2.5. Immunohistochemistry
Before enucleation, the superior pole for each mouse
eye was cauterized for orientation. Eyecups from each
transgenic line were prepared under infrared illumina-
tion at two time points: P21–P26 and P45–P50. The
eyecups were incubated in ﬁxative (4.0% paraformalde-
hyde, 0.5% glutaraldehyde in 0.1 M cacodylate buﬀer,
pH 7.2) for 2 h at room temperature, and subsequently
embedded in 30% sucrose in 0.1 M cacodylate buﬀer, pH
7.2 for 14–18 h at 4 C. The eyecups were hemisected,
embedded in Tissue Tek O.C.T. (Sakura Kinetek USA
Inc., Torrance, CA), and quickly frozen using liquid N2.
Using a Jung CM 3000 cryostat machine (Leica Inc.,
Deerﬁeld, IL), the tissues were sectioned at 10 lm
thickness. The sections were incubated for 1 h in block-
ing solution (2.0% bovine serum albumin (BSA), 0.3%
Triton X-100, and 2% goat serum in phosphate buﬀer
saline (PBS)), and incubated with either 1:25 dilution of
R2-12N or 1:200 dilution of 1D4 for 1 h. Dilution buﬀer
for primary antibody was 2.0% BSA, 2.0% goat serum in
PBS. Sections were washed for 3 5 min with plain di-
lution buﬀer and incubated for 30–45 min with 1:100
dilution of FITC-conjugated rabbit anti-mouse IgG
(Vector Laboratories Inc., Burlingame, CA). Sections
were washed for 3 5 min with plain dilution buﬀer and
for 2 5 min with PBS. Sections were incubated for 5
min in 4.0% paraformaldehyde in PBS and washed for
2 5 min with PBS. A tiny drop of Vectashield (Vector
Laboratories Inc., Burlingame, CA) was placed on the
sections, which then were cover slipped. Prepared cryo-
stat sections were viewed and analyzed using a LSM 510
confocal microscope (Carl Zeiss Inc., Thornwood, NY).
2.6. Retinal morphometry
Before enucleation, the superior pole was cauterized
for orientation. Eyecups from dark-reared mice were
prepared under infrared light at two time points: P21–
P26 and P45–P50. The eyecups were ﬁxed overnight at
4 C in 1=2 Karnovsky buﬀer (2.5% glutaraldehyde,
2.0% paraformaldehyde in 0.1 M cacodylate buﬀer, pH
7.2) during which the lenses were removed after the ﬁrst
15 minutes. The ﬁxed eyecups were washed for 3 10
min with 0.1 M cacodylate buﬀer, pH 7.2 and further
ﬁxed with 1% osmium tetraoxide in 0.1 M cacodylate
buﬀer for 1.5–2.0 h at room temperature. Eyecups were
washed 2 10 min with 0.1 M cacodylate buﬀer, pH 7.2
and dehydrated in the following manner: 15 min each
with 50%, 70%, 85%, and 95% ethanol; 3 10 min 100%
ethanol; and 2 10 min 100% propylene oxide. Inﬁl-
tration with epon (28.7% w/w epon 812, 14.4% w/w epon
826, 4.8% w/w epon 871, 46.4% w/w DDSA, 5.7% w/w
NMA, and 3% BDMA) was performed as follows:
overnight incubation with 1:1 epon: propylene oxide;
overnight incubation with 2:1 epon: propylene oxide;
and 6 h to overnight incubation with 100% epon. The
eyecups were placed in molds ﬁlled with epon with the
optic nerve in back and the superior pole pointing at 12
o’clock. The samples were baked for 3–4 days at 55 C.
Once hardened, the epon-embedded eyes were cut
into 1 lm sections and stained with Richardson stain
(0.5% methylene blue, 0.5% Azine II, and 0.5% borax in
dH2O). Analysis by retinal morphometry was accom-
plished by counting the outer nuclear layer thickness in
four distinct regions of the retina using the SlideBook
3.0 software (Intelligent Imaging Innovations, Inc.,
Denver, CO). Comparisons were made between mice
expressing the S334ter rhodopsin and age-matched
controls expressing no transgene in an equivalent endo-
genous rhodopsin background.
3. Results
3.1. Transgene expression levels and rod outer segment
formation
Transgenic mice expressing S334ter (Fig. 1A) were
bred with wildtype and rhodopsin knockout mice to
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obtain mice that expressed the S334ter transgene in
the rhodopsin þ=þ, þ= or = background
(S334terrhoþ=þ S334terrhoþ= or S334terrho=, respec-
tively). A transgenic line expressing full-length rhodop-
sin bearing an Ala substitution, S338A, was chosen as a
control based on its similar transgene mRNA expression
levels as the S334ter line (Fig. 1B). Since constitutive
signaling through the phototransduction cascade has
been implicated as a stimulus for photoreceptor cell
death (Chen et al., 1999; Chen, Simon, Matthes, Ya-
sumura, & Lavail, 1999) and to avoid this condition
caused by S334ter (Chen et al., 1995), all mice were
raised in constant darkness. Levels of transgene ex-
pression were determined by quantitating the amount of
transgene transcript in each line at post-natal day 21–26.
Rod opsin mRNA were ampliﬁed with primers that
amplify both the endogenous and mutant rod opsin
genes and, subsequently, was digested with restriction
enzymes speciﬁc for the transgene (see Section 2).
Transgene transcript in S334ter and S338A mice was
determined to be 10% of the total in the rhodopsin
þ=þ background.
Although expressed at only 10% level, the S338A
transgene was able to fully reconstitute the rod outer
segments in the rhodopsin = background (Fig. 2,
compare B to A). Immunolocalization of rhodopsin
using a monoclonal antibody recognizing the rhodop-
sin amino terminus (R2-12N) showed correct rhodopsin
localization to the rod outer segments (Fig. 2, C and D),
similar to the wildtype control (Fig. 4A). Therefore,
S338A rhodopsin contains all the necessary elements for
correct rhodopsin transport and localization. This ob-
servation is consistent with our previous ﬁnding that
mutations at any of the Ser and Thr sites did not aﬀect
rhodopsin transport (Mendez et al., 2000; Mendez,
Krasnoperova et al., 2000).
Fig. 1. Comparison of transgene expression in S334ter and S338A transgenic lines. (A) The 11 kb Bam HI fragment of mouse rhodopsin gene. The
S334ter rhodopsin construct was generated by introducing a stop codon at position 334 (Chen et al., 1995). A transgenic line in which Ser338 was
substituted to Ala was selected as the control line among a collection of rhodopsin mutants at the phosphorylation sites (Mendez et al., 2000) because
it best matched S334ter level of expression. (B) Determination of the transgene-to-total rhodopsin transcript ratio, for S334ter (left panel) and S338A
rhodopsin (right panel). Total rhodopsin transcript from transgenic retinas was ampliﬁed by RT-PCR and divided into two equal fractions. One was
loaded directly (left lane), the other was digested with a restriction enzyme speciﬁc for the transgene and then loaded (right lane) into a 12%
polyacrylamide gel. Transgene level of expression was determined to be 10% in both cases.
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3.2. Transport of S334ter in the rhodopsin þ=þ and the
rhodopsin = genetic background
Retinal morphology of mice expressing S334ter in the
rhodopsin þ=þ, þ= and = background was ex-
amined to see whether S334ter was able to contribute to
rod outer segment formation. In contrast to S338A,
rhodopsin = mice expressing Ser334ter transcript to
10% of the normal rhodopsin mRNA levels failed to
form rod outer segments. As can be seen in Fig. 3, the
overall retinal morphology was not aﬀected by the
presence of S334ter transgene in any rhodopsin back-
ground. In the rhodopsin þ=þ or þ= background, no
diﬀerences were observed at the outer nuclear layer
thickness or at the length of the rod outer segments
between transgene-positive or negative control mice. In
the rhodopsin = background, no outer segment for-
mation was observed either in the absence or presence of
the transgene. These results indicate that the rhodopsin
carboxyl-terminus is required either directly or indi-
rectly, for rod outer segment formation.
Expression of the truncated rhodopsin in
S334terrho= mice was conﬁrmed by immunoﬂuores-
cence staining using monoclonal antibody R2-12N (Fig.
4). In the rhodopsin = background where rod outer
segments were absent, S334ter was mis-localized to the
outer nuclear layer and the inner segments (Fig. 4C).
Similar mis-localization of S334ter in the rhodopsin
þ=þ background was also suggested by the R2-12N
staining pattern when compared to the wildtype control
(Fig. 4, compare B to A), with the signal in this case
being additive from both S334ter and endogenous rho-
dopsins. Taken together, these results show that in the
absence of the carboxyl-terminus and the absence of
endogenous rhodopsin, S334ter rhodopsin molecules are
randomly distributed in the rod cell.
Expression of the truncated rhodopsin protein in
transgenic retinas was also conﬁrmed by immunoblot
analysis (Fig. 5). Both the endogenous and the truncated
S334ter rhodopsin molecules were detected in the
S334terrhoþ=þ sample, whereas only the truncated rho-
dopsin was present in the S334terrho= sample. As
expected, the control S338A rhodopsin was indistin-
guishable in size from the wildtype rhodopsin. Despite
their similar levels of transgene transcript, S334ter and
S338A transgenic lines showed a strikingly diﬀerent
amount of mutant protein. As shown in Fig. 5, the
Fig. 3. Retinal morphology of Ser334ter transgene-positive versus
negative control mice in the rhodopsin þ=þ, þ= and = back-
ground. Shown are 1 lm retinal sections from rhodopsin þ=þ, þ=
and = mice at 45–50 post-natal days (left row), or corresponding
littermates expressing the S334ter transgene (S334terrhoþ=þ,
S334terrhoþ= and S334terrho=, right row). No diﬀerences in overall
retinal morphology were observed between transgene-positive mice
and littermate controls.
Fig. 2. Expression of the control rhodopsin transgene (S338A) restores
rod outer segment formation in rhodopsin=mice. Shown are 1 lm-
thick retinal sections from rhodopsin = mice (A) or S338Arho=
mice (B), at 45 post-natal days. Immunolocalization of rhodopsin with
mAb R2-12N shows localization of rhodopsin to rod outer segments
(C, dark ﬁeld; D, bright ﬁeld).
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amount of rhodopsin in S334terrho= is dramatically
lower than the amount of rhodopsin present in the
S338Arho= retina. This diﬀerence is likely due to a lack
of rod outer segment disks in the S334terrho= retina,
which precludes the accommodation and accumulation
of transported rhodopsin molecules. In the absence of
this structure, S334ter is likely targeted for degradation,
resulting in lowered protein concentration.
Previous evidence indicate that some S334ter protein
do traﬃc to the outer segment when endogenous rho-
dopsin is present. This observation is based on func-
tional studies of S334ter in rod outer segments using
single cell recordings and immunoblot analysis of rho-
dopsin from isolated rod outer segment preparations
from transgenic mice expressing S334ter in the rho-
dopsin þ=þ background (Chen et al., 1995). The result
that mutant rhodopsin lacking the correct traﬃcking
signal is able to transport to the rod outer segment in the
presence of endogenous rhodopsin is consistent with
published studies from other laboratories (Green et al.,
2000; Li et al., 1996; Sung et al., 1994). Together, these
results indicate that mutant rhodopsins lacking the
correct traﬃcking signal can be co-transported to the rod
outer segment along with normal rhodopsin. The mis-
localization and the lack of outer segment structures in
the S334terrho= retinas demonstrate that the last 15
amino acids of the carboxyl-terminal domain contain a
signal that is essential for rhodopsin transport.
3.3. Inﬂuence of S334ter on translocation of endogenous
rhodopsin
Because endogenous rhodopsin does aﬀect the
translocation of S334ter, we explored the possibility
that the reverse might also occur—that the presence of
S334ter causes improper localization of endogenous
rhodopsin. Retinal sections from S334terrhoþ=þ and age-
matched non-transgenic control mice were stained
with the monoclonal antibody 1D4 that recognized the
carboxyl-terminal eight amino acids of rhodopsin
(Hodges, Heaton, Parker, Molday, & Molday, 1988),
and is therefore speciﬁc for the endogenous rhodopsin
(Fig. 6). In wildtype retina rhodopsin was detected
predominantly in the rod outer segment as expected.
Light staining in the outer nuclear layer and a lack of
staining in the inner segment indicate that rhodopsin
is present in low amounts in the outer nuclear layer
and largely absent in the inner segment (Fig. 6A). In
S334terrhoþ=þ retinas strong staining was also seen in the
rod outer segment, indicating that the majority of
wildtype rhodopsin resides in this region. However, in-
creased signal was seen in the outer nuclear layer and the
inner segment when compared to the corresponding
layers within the wildtype retina. This diﬀerence is
highlighted in Fig. 6C and D, which show a higher
magniﬁcation of the inner segment and outer segment
layers. Here, rhodopsin reactivity at the inner segment is
absent in the control retina (Fig. 6D) but apparent in the
S334terrhoþ=þ retina (Fig. 6C, arrowheads). Together,
these observations show that the presence of S334ter
Fig. 5. Western blot analysis of Ser334ter and S338A rhodopsin in
transgenic lines. The same amount of retinal homogenate (8 105
retina equivalents) from Ser334terrhoþ=þ and a wildtype littermate
control were compared by 12% SDS-PAGE after incubation with R2-
12N mAb. Ser334ter rhodopsin is detected as a faster migrating spe-
cies, given its 15 amino acids diﬀerence in size. More sample
(3:2 104 retinal equivalents) was loaded from Ser334terrho= and
S338Arho= retinas in the same gel to compare rhodopsin transgene
expression. Although transgenic lines with similar transcript expres-
sion levels were selected, there is a signiﬁcant diﬀerence in terms of
protein expression. This diﬀerence can be explained by the presence
of a ROS layer in the S338Arho= retina, and its absence in the
S334terrho= retina.
Fig. 4. In the absence of endogenous rhodopsin, Ser334ter rhodopsin localizes to the outer nuclear layer and inner segments of photoreceptors.
Immunolocalization of rhodopsin with mAb R2-12N in frozen retinal sections from 21–26 day-old wildtype (A), Ser334terrhoþ=þ (B), and
Ser334terrho= (C). R2-12N mAb recognizes residues 2–12 from the rhodopsin NH2-terminus, and therefore recognizes both the endogenous and
transgenic rhodopsins. In the rhodopsin = background, S334ter fails to restore rod outer segments and is randomly distributed in the inner
segments (IS) and outer nuclear layer (ONL). Note also the increased signal at the outer nuclear layer and inner segments in Ser334terrhoþ=þ sections.
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does aﬀect normal traﬃcking of endogenous rhodopsin
albeit to a relatively small degree.
3.4. S334ter mis-localization does not accelerate retinal
degeneration
Outer nuclear thickness was measured at four diﬀer-
ent retinal regions across the span of the retina to
compare the eﬀect of S334ter mis-localization on
photoreceptor cell survival in rhodopsin þ=þ and =
backgrounds at two diﬀerent ages (Fig. 7). Measure-
ments along the span of the retina were necessary be-
cause the rhodopsin promoter tends to exhibit a
gradient of expression, with the superior pole of the
retina showing a stronger expression pattern (Lem,
Applebury, Falk, Flannery, & Simon, 1991). Consistent
with previous reports, retinas from rhodopsin = mice
showed a progressive loss of photoreceptors as a func-
tion of age (compare the left panels with the right pan-
els) (Humphries et al., 1997; Lem et al., 1999). Measured
outer nuclear layer thickness from mice expressing
S334ter (ﬁlled bars) were the same as the corresponding
rhodopsin þ=þ and = controls (white bars) along the
span of the retina at both time points. These results
demonstrate that rhodopsin mis-localization in itself is
not a strong stimulus for photoreceptor cell death.
4. Discussion
Recent evidence from both in vitro and in vivo
studies clearly demonstrates a direct role of rhodopsin’s
Fig. 7. Ser334ter rhodopsin expression does not lead to cell death. Retinal outer nuclear layer (ONL) thickness was measured at 3.5 or 7 post-natal
weeks in Ser334ter-expressing mice (black bars) and negative littermate controls (white bars) in the rhodopsin þ=þ (left panels) or = (right panels)
genetic background. ONL thickness was measured at four diﬀerent regions across a vertical section of the retina at or near the optic nerve (A–D,
retinal diagram; S: superior, I: inferior). ONL thickness, expressed in lm, is the average of N ¼ 4–6 determinations per genotype per time point.
Error bars represent the standard deviation.
Fig. 6. Endogenous rhodopsin mis-localizes to the inner segments in
the presence of Ser334ter rhodopsin. Retinal sections were incubated
with mAb 1D4, which recognizes rhodopsin’s last eight carboxyl-
terminal amino acids. MAb 1D4 does not recognize the Ser334ter
truncated rhodopsin, and is therefore speciﬁc for the endogenous
rhodopsin. A and C, S334terrhoþ=þ; B and D, wildtype. A and B,
40magniﬁcation; C and D, 126magniﬁcation. At each magniﬁ-
cation, the same exposure time was used to take the pictures. Note the
brighter signal in the outer nuclear layer (ONL) and rod inner segment
(RIS) of the S334terrhoþ=þ section (A) than of the wildtype control (B).
Arrows in C point to photoreceptor inner segments that were immu-
noreactive to mAb 1D4. These results indicate that the presence of
Ser334ter causes the mis-localization and/or retention of the endoge-
nous rhodopsin in the ONL and IS to some extent.
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carboxyl-terminus in its vectorial transport. However,
the in vivo studies using transgenic animals do not ad-
dress whether the carboxyl-terminal domain is abso-
lutely required for transport because the expressed
mutant rhodopsins do traﬃc to the outer segment in the
presence of endogenous rhodopsin. Is correct transport
of mutant rhodopsin due to traﬃcking signals residing
in other domains distinct from the carboxyl-terminus?
Or, are the mutant rhodopsin molecules co-transported
with the endogenous wildtype rhodopsin? We expressed
a carboxyl-terminal truncation mutant, S334ter, in the
presence and absence of endogenous rhodopsin to ad-
dress these questions.
Normal retinal architecture can be obtained by ex-
pressing a normal human rhodopsin transgene in the
rhodopsin knockout mice (McNally et al., 1999). Our
result from S338Arho= also established that 10% ex-
pression level of a rhodopsin phosphorylation site mu-
tant transgene could restore normal retinal morphology
in rhodopsin knockout mice. In contrast, S334ter failed
to restore an outer segment in the rhodopsin = ret-
ina. Because rhodopsin also is required for outer seg-
ment formation from a structural point of view, the lack
of outer segments in S334terrho= retinas might be due
to its inability to maintain a stable disc structure.
However, the COOH-domain is cytoplasmic and highly
dynamic (Langen, Cai, Altenbach, Khorana, & Hubbell,
1999) and therefore is unlikely to contribute to struc-
tural stability. Rather, the lack of outer segment for-
mation is most likely due to transport defects of S334ter
resulting from the lack of the required traﬃcking signal.
Thus, because rhodopsin-bearing vesicles are not prop-
erly transported to the apical surface, the outer segment
fails to form. Recently, Tam et al. (2000) showed that
the carboxyl-terminal 44 amino acid tail of rhodopsin,
when fused to GFP, targets this fusion protein exclu-
sively to the rod outer segment of transgenic frog retina.
Our observation that S334ter rhodopsin fails to be
transported, together with the carboxyl-terminus alone
being suﬃcient to direct transport to the outer segment
in the transgenic frog experiment, provides strong evi-
dence that the carboxyl-terminal domain is necessary
and suﬃcient for rhodopsin transport, and that there are
no other traﬃcking signals residing in other domains
that might serve redundant functions.
Why did the previous transgenic animal studies show
the mutant rhodopsins to be localized to the outer seg-
ment? Our results suggest that the mutant rhodopsin
molecules are co-transported with the endogenous rho-
dopsin. The post-Golgi vesicles containing rhodopsin
are 300 nm in diameter (Deretic & Papermaster, 1991),
and it has been estimated that these vesicles could con-
Fig. 8. Schematic model showing Ser334ter and endogenous rhodopsin being co-transported in post-Golgi vesicles. Rhodopsin is synthesized at the
rough endoplasmic reticulum in the proximal inner segment of rod photoreceptors. In its journey to rod outer segments, where phototransduction
takes place, it is ﬁrst transported in post-Golgi membrane vesicles to the base of the connecting cilium. These 300 nm diameter vesicles contain up to
2000 rhodopsin molecules. Ser334ter and endogenous rhodopsin could therefore coexist in these rhodopsin-laden vesicles. Given that the rhodopsin
carboxyl terminal domain has been involved in the sorting of these vesicles through the inner segment, co-localization of both rhodopsins within the
same vesicles would explain both the presence of S334ter at rod outer segments in the rhodopsin þ=þ background, and the mis-localization of
endogenous rhodopsin at the inner segments observed to some degree in the presence of the truncated rhodopsin.
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tain 2000 rhodopsin molecules (Tam et al., 2000).
When wildtype rhodopsin is present in the majority or
even at 50%, it can be expected that each vesicle will
contain suﬃcient targeting signals from the wildtype
protein. By this mechanism, the mutant proteins follow
the bulk ﬂow of normal rhodopsin to the outer segment
(Fig. 8). The same mechanism may also explain why
S334ter aﬀected localization of a small amount of
endogenous rhodopsin to the inner segment and outer
nuclear layer. It is possible that an over-threshold in-
corporation of the truncated rhodopsin in some vesicles
might have led to failed transport of both S334ter and
endogenous rhodopsins to these regions.
Failed rhodopsin transport may be a contributing
factor to the pathogenesis of rod photoreceptors in
retinitis pigmentosa or macular degeneration (Sung &
Tai, 2000). To see if this is the case, we performed
careful morphometric measurements on the outer nu-
clear layer thickness to see whether S334ter expression
aﬀected photoreceptor cell survival in rhodopsin þ=þ
and = retinas. Surprisingly, no diﬀerence in retinal
thickness was observed between retinas expressing
S334ter and the corresponding control retinas either
at an early time point (three weeks), before noticeable
thinning of the outer nuclear layer was observed in the
rhodopsin = retina, or at a later time point (seven
weeks), where the outer nuclear layer of the rhodopsin
= retina was halved in thickness. This is in contrast
to the ﬁnding of Green et al. (2000) who found that 10%
expression level of the same murine S334ter construct in
transgenic rats caused retinal degeneration both in light-
reared and dark-reared animals. The discrepancy be-
tween the two diﬀerent results may be due to a diﬀerence
in animal model used or diﬀerence in environmental
factors such as rearing conditions.
Rhodopsin mutations at the carboxyl-terminus cause
an autosomal dominantly inherited form of retinal de-
generation in humans. Therefore, only one aﬀected allele
is suﬃcient to cause the disease phenotype, so it can be
expected that in human disease, mutant rhodopsins will
be expressed at 50% of the total rhodopsin population.
The lack of eﬀect by S334ter in our studies may be due
to the relatively low expression level of this transgene.
Doubling the gene dosage by breeding the S334ter
transgene to homozygosity should bring the expression
level to 20%, which is more in line with the expression
levels in human disease. Future experiments will be
conducted to see whether 20% expression of S334ter will
have an eﬀect on photoreceptor cell survival.
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